Aegis Capital Starts BiondVax Pharmaceuticals (BVXV) at Buy
Tweet
Share
E-mailGet Alerts BVXV Hot Sheet
Price: $1.36 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Aegis Capital earlier initiated coverage on BiondVax Pharmaceuticals (NASDAQ: BVXV) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on BiondVax Pharmaceuticals click here. For more ratings news on BiondVax Pharmaceuticals click here.
Shares of BiondVax Pharmaceuticals closed at $4.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scotiabank Starts Webull (BULL) at Sector Outperform
- H.C. Wainwright Starts Eagle Nuclear Energy (NUCL) at Buy
- WBB Securities Starts Vogenx (VOGX) at Speculative Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
